Literature DB >> 20143961

Clinical efficacy of Japanese traditional herbal medicine (Kampo) in patients with late-onset hypogonadism.

Toshiyasu Amano1, Tetsuya Imao, Katsurou Takemae.   

Abstract

INTRODUCTION: In addition to hormone replacement therapy, non-hormonal therapy, particularly Japanese traditional herbal medicine (Kampo), has been used to alleviate the various symptoms of female menopause. The efficacy and safety of Japanese traditional herbal medicine for male late-onset hypogonadism (LOH) are investigated.
METHODS: One hundred fifty-one patients with LOH were treated via the administration of Japanese traditional herbal medicine. The most appropriate Japanese traditional herbal medicine was administered to patients according to their pathogenic alteration. After 4 weeks, the clinical efficacy was evaluated based on improvement of LOH symptoms and the score of the simplified menopausal index (SMI). Additionally, predictive factors of efficacy of Japanese traditional herbal medicine were analyzed.
RESULTS: Among 151 patients with LOH, 63 (41.8%) achieved both relief from LOH symptoms and normalized SMI score (Excellent response group), whereas 44 (29.1%) achieved either relief from LOH symptoms or normalized SMI score (Fair). However, 44 (29.1%) patients displayed neither relief from LOH symptoms nor normalized SMI score (Poor). Adverse reactions were observed only in four (2.6%) patients. Patients displaying excess conditions and mild LOH symptoms appeared to be superior candidates for Japanese traditional herbal medicine.
CONCLUSION: Japanese traditional herbal medicine is an effective and safe treatment for LOH.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20143961     DOI: 10.3109/13685530903536684

Source DB:  PubMed          Journal:  Aging Male        ISSN: 1368-5538            Impact factor:   5.892


  6 in total

Review 1.  Recent topics related to testosterone deficiency syndrome in Japan.

Authors:  Akira Tsujimura; Norio Nonomura
Journal:  Asian J Androl       Date:  2011-04-04       Impact factor: 3.285

2.  Efficacy and safety of keishibukuryogan, a traditional Japanese Kampo medicine, for hot flashes in prostate cancer patients receiving androgen deprivation therapy.

Authors:  Kazuyoshi Shigehara; Kouji Izumi; Kazufumi Nakashima; Shohei Kawaguchi; Takahiro Nohara; Yoshifumi Kadono; Atsushi Mizokami
Journal:  Transl Androl Urol       Date:  2020-12

Review 3.  Environmental Factors-Induced Oxidative Stress: Hormonal and Molecular Pathway Disruptions in Hypogonadism and Erectile Dysfunction.

Authors:  Shubhadeep Roychoudhury; Saptaparna Chakraborty; Arun Paul Choudhury; Anandan Das; Niraj Kumar Jha; Petr Slama; Monika Nath; Peter Massanyi; Janne Ruokolainen; Kavindra Kumar Kesari
Journal:  Antioxidants (Basel)       Date:  2021-05-24

4.  Effects of Saikokaryukotsuboreito on Spermatogenesis and Fertility in Aging Male Mice.

Authors:  Zhi-Jun Zang; Su-Yun Ji; Ya-Nan Zhang; Yong Gao; Bin Zhang
Journal:  Chin Med J (Engl)       Date:  2016-04-05       Impact factor: 2.628

Review 5.  Phytotherapy: emerging therapeutic option in urologic disease.

Authors:  Sae Woong Kim
Journal:  Transl Androl Urol       Date:  2012-09

6.  Antioxidant and Antifibrotic Effect of a Herbal Formulation In Vitro and in the Experimental Andropause via Nrf2/HO-1 Signaling Pathway.

Authors:  Woong Jin Bae; Guan Qun Zhu; Sae Woong Choi; Hyun Cheol Jeong; Fahad Bashraheel; Kang Sup Kim; Su Jin Kim; Hyuk Jin Cho; U Syn Ha; Sung Hoo Hong; Ji Youl Lee; Hyun-A Oh; Hye Cheong Koo; Do Ram Kim; Sung Yeoun Hwang; Sae Woong Kim
Journal:  Oxid Med Cell Longev       Date:  2017-09-17       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.